Manage a portfolio of 15+ early-stage life sciences companies commercializing medical devices, diagnostics, and therapeuticsDefine product vision and execute strategic objectives collaboratively with portfolio teams; serve on the Board of Directors for select companiesGrow and manage relationships between faculty and clinician founders, entrepreneurs, investors, external partners, and other stakeholders to establish high-performing teams

Cogwear's comfortable wearable technology delivers clinical-grade cognitive feedback anywhere, anytime.

Developing non-invasive wearable devices for automated stroke detection and alerting to enable rapid intervention.

Developing a rapid diagnostic platform to assess bleeding and thrombotic risk in patients.

Vetigenics is an animal health biopharmaceutical company committed to improving canine health through the development of entirely canine, safe and effective antibody-based immunotherapies to treat cancer, infectious disease and other chronic conditions.

Developing a breakthrough treatment for acute lung injury by targeting a novel pathway.

Developing a novel, mechanically-responsive drug delivery technology for orthopaedic tissue regeneration.

Developing neurosurgical innovations that improve safety and accessibility, leading to better patient outcomes and lower healthcare costs.

Deploying decision clinical support technology for early intervention of postpartum hemorrhage to improve maternal outcomes and health equity

Blazing the trail for controllable cell therapy to treat cancer using a flexible antigen targeting platform.

Developing novel therapeutics for acute intervention in neurological diseases.

Developing an advanced blood-based diagnostic test to predict a patient’s responsiveness to cancer immunotherapy drugs.

Developing the first implantable, tissue engineered neural pathways that can physically reconstruct lost brain circuitry in patients.

Established a high throughput model of cartilage injury using micro-engineered constructs as a reliable tool to screen and identify new candidates for the treatment of post-traumatic osteoarthritis.Designed a mechanically-responsive drug delivery system using polymeric microcapsules to actively deliver therapeutics in the demanding mechanical environment of the joint for cartilage repair.Received independent funding through the NSF Graduate Research Fellowship and NIH T32 training grant, and successfully contributed to awarded VA Merit and NIH R01 grants.Advisors: Robert L. Mauck and George R. Dodge

Characterized cell source-dependent sensitivity to pro-inflammatory cytokines in an engineered cartilage model using mesenchymal stem cells and chondrocytes.Built a high throughput mechanical testing system for 48 samples in parallel to enable combinatorial assays. Improved the efficiency of testing by 90% compared to single sample testing.